Beatriz Arteta

Prof. Beatriz Arteta

Cell Biology and Histology, University of the Basque Country (UPV/EHU), Leioa, Spain
orcid

Research Focus & Metrics

Academic Career Length

27Years (2000-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
2 August 2017 in Oncology Letters
Verified
Journal Article
Closed access
PDF file
ABAitor Benedicto
Aitor Benedicto
IRIrene Romayor
Irene Romayor
BABeatriz Arteta
Beatriz Arteta
Intercellular adhesion molecule (ICAM)-1, is a transmembrane glycoprotein of the immunoglobulin (Ig)-like superfamily, consisting of five extracellular Ig‑like domains, a transmembrane domain and a short cytoplasmic tail. ICAM‑1 is expressed in various cell types, including endothelial cells and leukocytes, and is involved in several physiological processes. Furthermore, it has additionally been reported to be expressed in various cancer cells, including melanoma, colorectal cancer and lymphoma. The majority of studies to date have focused on the expression of the ICAM‑1 on the surface of tumor cells, without research into ICAM‑1 expression at sites of metastasis. Cancer cells frequently metastasize to the liver, due to its unique physiology and specialized liver sinusoid capillary network. Liver sinusoidal endothelial cells constitutively express ICAM‑1, which is upregulated under inflammatory conditions. Furthermore, liver ICAM‑1 may be important during the development of liver metastasis. Therefore, it is necessary to improve the understanding of the mechanisms mediated by this adhesion molecule in order to develop host‑directed anticancer therapies.

10 May 2012 in Hepatology
Verified
Journal Article
Open access
PDF file
AWAshwin Woodhoo
Ashwin Woodhoo
MIMarta Iruarrizaga-Lejarreta
Marta Iruarrizaga-Lejarreta
NBNaiara Beraza
Naiara Beraza
JGJuan Luis García-Rodríguez
Juan Luis García-Rodríguez
NENieves Embade
Nieves Embade
Maria Luz Martinez-ChantarMaria Luz Martinez-Chantar
Maria Luz Martinez-Chantar
RNA-binding proteins (RBPs) play a major role in the control of messenger RNA (mRNA) turnover and translation rates. We examined the role of the RBP, human antigen R (HuR), during cholestatic liver injury and hepatic stellate cell (HSC) activation. HuR silencing attenuated fibrosis development in vivo after BDL, reducing liver damage, oxidative stress, inflammation, and collagen and alpha smooth muscle actin (α-SMA) expression. HuR expression increased in activated HSCs from bile duct ligation mice and during HSC activation in vitro , and HuR silencing markedly reduced HSC activation. HuR regulated platelet-derived growth factor (PDGF)-induced proliferation and migration and controlled the expression of several mRNAs involved in these processes (e.g., Actin , matrix metalloproteinase 9, and cyclin D1 and B1 ). These functions of HuR were linked to its abundance and cytoplasmic localization, controlled by PDGF, by extracellular signal-regulated kinases (ERK) and phosphatidylinositol 3-kinase activation as well as ERK/LKB1 (liver kinase B1) activation, respectively. More important, we identified the tumor suppressor, LKB1, as a novel downstream target of PDGF-induced ERK activation in HSCs. HuR also controlled transforming growth factor beta (TGF-β)-induced profibrogenic actions by regulating the expression of TGF -β, α- SMA , and p21 . This was likely the result of an increased cytoplasmic localization of HuR, controlled by TGF-β-induced p38 mitogen-activated protein kinase activation. Finally, we found that HuR and LKB1 (Ser428) levels were highly expressed in activated HSCs in human cirrhotic samples. Conclusion : Our results show that HuR is important for the pathogenesis of liver fibrosis development in the cholestatic injury model, for HSC activation, and for the response of activated HSC to PDGF and TGF-β.

1 September 2010 in PLOS ONE
Verified
Journal Article
Open access
PDF file
MPMarta Pérez-Garay
Marta Pérez-Garay
BABeatriz Arteta
Beatriz Arteta
LPLluís Pagès
Lluís Pagès
RLRafael de Llorens
Rafael de Llorens
CBCarme de Bolòs
Carme de Bolòs
Rosa PeracaulaRosa Peracaula
Rosa Peracaula
Cell surface sialylation is emerging as an important feature of cancer cell metastasis. Sialyltransferase expression has been reported to be altered in tumours and may account for the formation of sialylated tumour antigens. We have focused on the influence of alpha-2,3-sialyltransferase ST3Gal III in key steps of the pancreatic tumorigenic process. ST3Gal III overexpressing pancreatic adenocarcinoma cell lines Capan-1 and MDAPanc-28 were generated. They showed an increase of the tumour associated antigen sialyl-Lewisx. The transfectants' E-selectin binding capacity was proportional to cell surface sialyl-Lewisx levels. Cellular migration positively correlated with ST3Gal III and sialyl-Lewisx levels. Moreover, intrasplenic injection of the ST3Gal III transfected cells into athymic nude mice showed a decrease in survival and higher metastasis formation when compared to the mock cells. In summary, the overexpression of ST3Gal III in these pancreatic adenocarcinoma cell lines underlines the role of this enzyme and its product in key steps of tumour progression such as adhesion, migration and metastasis formation.

1 August 2013 in The International Journal of Biochemistry & Cell Biology
Verified
Journal Article
Closed access
MPMarta Pérez-Garay
Marta Pérez-Garay
BABeatriz Arteta
Beatriz Arteta
ELEsther Llop
Esther Llop
LCLara Cobler
Lara Cobler
LPLluís Pagès
Lluís Pagès
Rosa PeracaulaRosa Peracaula
Rosa Peracaula

11 September 2019 in Scientific Reports
Verified
Journal Article
Open access
PDF file
ABAitor Benedicto
Aitor Benedicto
AHAlba Herrero
Alba Herrero
IRIrene Romayor
Irene Romayor
JMJoana Marquez
Joana Marquez
BSBård Smedsrød
Bård Smedsrød
BABeatriz Arteta
Beatriz Arteta
The prometastatic stroma generated through tumor cells/host cells interaction is critical for metastatic growth. To elucidate the role of ICAM-1 on the crosstalk between tumor and primary liver sinusoidal endothelial cells (LSECs) and hepatic stellate cells (HSCs), implicated in tumor adhesion and angiogenesis, we performed in vitro cocultures and an in vivo model of liver metastasis of colorectal cancer (CRC). ICAM-1 blockade in the LSECs decreased the adhesion and transmigration of tumor cells through an LSEC in vitro and vivo. Cocultures of C26 cells and LSECs contained higher amounts of IL-1β, IL-6, PGE-2, TNF-α and ICAM-1 than monocultures. C26 cells incubated with sICAM-1 secreted higher amounts of PGE-2, IL-6, VEGF, and MMPs, while enhanced the migration of LSECs and HSCs. HSCs cultures activated by media from C26 cells pretreated with sICAM-1 contained the largest amounts of VEGF and MMPs. C26 cell activation with sICAM-1 enhanced their metastasizing potential in vivo, while tumor LFA-1 blockade reduced tumor burden and LSECs and HSC-derived myofibroblasts recruitment. In vivo ICAM-1 silencing produced similar results. These findings uncover LSEC ICAM-1 as a mediator of the CRC metastatic cascade in the liver and identifies it as target for the inhibition of liver colonization and metastatic progression.

23 May 2010 in Hepatology
Verified
Journal Article
Open access
PDF file
BABeatriz Arteta
Beatriz Arteta
NLNerea Lasuen
Nerea Lasuen
ALAritz Lopategi
Aritz Lopategi
BSBaldur Sveinbjörnsson
Baldur Sveinbjörnsson
BSBård Smedsrφd
Bård Smedsrφd
FVFernando Vidal-Vanaclocha
Fernando Vidal-Vanaclocha
Mannose receptor (ManR)-mediated liver sinusoidal endothelial cell (LSEC) endocytosis plays a role in antigen presentation and innate immunity, but its role in hepatic metastasis is unknown. We studied ManR-mediated endocytosis during C26 colorectal cancer cell interaction with LSECs and its implications in metastasis. Uptake of labeled ManR ligands (mannan and ovalbumin) and immunohistochemistry were used to study ManR endocytosis and expression. Several interleukin (IL)-1 inhibitors and the cyclooxygenase-2 (COX-2) inhibitor celecoxib were used to analyze the role of IL-1 and COX-2 in ManR regulation. Anti-mouse ManR antibodies and ManR knockout (ManR−/−) mice were used to identify ManR-dependent mechanisms during antitumor immune response of liver sinusoidal lymphocytes (LSLs) interacting with tumor-activated LSECs. ManR expression and endocytosis increased in tumor-activated LSECs through a two-step mechanism: (1) Release of COX-2–dependent IL-1–stimulating factors by lymphocyte function–associated antigen-1–expressing C26 cells in response to intercellular adhesion molecule-1 (ICAM-1), which was expressed and secreted by tumor-activated LSECs; and (2) widespread up-regulation of ManR in LSECs through tumor-induced IL-1. In addition, LSLs that had interacted with tumor-activated LSECs in vivo decreased their antitumor cytotoxicity and interferon (IFN)-gamma secretion while they increased IL-10 release ex vivo . IFN-gamma/IL-10 ratio also decreased in the hepatic blood from tumor-injected mice. Immunosuppressant effects of tumor-activated LSECs on LSLs were abrogated in both LSECs from ManR−/− mice and tumor-activated LSECs given anti-mouse ManR antibodies. Conclusion : ICAM-1–induced tumor COX-2 decreased antitumor activity during hepatic metastasis through IL-1–induced ManR. ManR constituted a common mediator for prometastatic effects of IL-1, COX-2, and ICAM-1. A rise in hepatic IFN-gamma/IL-10 ratio and antitumor cytotoxicity by way of ManR blockade is consistent with the antimetastatic effects of IL-1, COX-2, and ICAM-1 inhibitors. These data support ManR and ManR-stimulating factors as targets for hepatic colorectal metastasis therapy. Hepatology 2010;51:2172–2182